•  
  •  
  •  
  •  

2025-10-02 06:21:26

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  FinolexIndustries

Stock Report

  • Finolex Industries Ltd posts consolidated Q2FY25 net profit of Rs. 40.67 crores
  • Finolex Industries Ltd Q1 FY2024-25 consolidated net profit surges to Rs. 500.73 crores
  • Finolex Industries Ltd Q4 FY2023-24 consolidated net profit at Rs. 164.90 crores
  • Finolex Industries Ltd enters into SPA for purchase of solar power under captive power policy
  • Finolex Industries Ltd unveils new logo
  • Finolex Industries Ltd Q3 FY2024 consolidated PAT slips QoQ to Rs. 95.40 crores
  • Finolex Industries Ltd consolidated Q1FY24 PAT declines QoQ to Rs. 115.33 crores
  • Mr. Ajit Venkataraman appointed as MD of Finolex Industries Limited
  • Finolex Industries Ltd recommends final dividend of Rs. 1.50
  • Finolex Industries Ltd Q4 FY2022-23 consolidated net profit rises QoQ to Rs. 166.50 crores
  • Finolex Industries Ltd commissions new manufacturing facility at Pune
  • Finolex Industries Ltd Q3 FY2023 consolidated profit at Rs. 79.54 crores
  • Finolex Industries Ltd Q2 FY2023 consolidated loss at Rs. 95.38 crores
  • Finolex Industries Ltd consolidated Q1 FY2023 net profit falls to Rs. 99.22 crores
  • Finolex Industries Ltd recommends final dividend of Rs. 2 and special dividend of Rs. 2
  • Finolex Industries posts Rs. 495.12 crores consolidated profit in Q4FY22
  • Finolex Industries accredited with 'Responsible Care Logo' by Indian Chemical Council
  • Finolex Industries consolidated Q3 FY22 PAT falls to Rs. 177.43 crores
  • Finolex Industries Ltd reports rise in Q2FY22 consolidated PAT to Rs. 233.25 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024